Inducing CCR5&#916;32/&#916;32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology.

Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology.

Qi, Chunxia; Li, Dan; Jiang, Xiangxiang; Jia, Xiaopeng; Lu, Lingling; Wang, Yanfeng; Sun, Jinhuan; Shao, Yiming; Wei, Min.

Afiliação

Qi C; School of Medicine, Nankai University, Tianjin, China.
Li D; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jiang X; School of Medicine, Nankai University, Tianjin, China.
Jia X; School of Medicine, Nankai University, Tianjin, China.
Lu L; School of Medicine, Nankai University, Tianjin, China.
Wang Y; School of Medicine, Nankai University, Tianjin, China.
Sun J; School of Medicine, Nankai University, Tianjin, China.
Shao Y; School of Medicine, Nankai University, Tianjin, China; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wei M; School of Medicine, Nankai University, Tianjin, China; Nankai University Second People's Hospital, School of Medicine, Nankai University, Tianjin, China. Electronic address: weimin@nankai.edu.cn.